Cargando…

Neuronal and Neuroaxonal Damage Cerebrospinal Fluid Biomarkers in Autoimmune Encephalitis Associated or Not with the Presence of Tumor

The aim of this study was to evaluate the association of neuronal damage biomarkers (neurofilament light chain (NFL) and total tau protein (T-tau)) in the CSF of patients with autoimmune encephalitis (AE) with the presence of an underlying malignancy and to determine correlations with patient charac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vakrakou, Aigli G., Tzartos, John S., Strataki, Eleni, Boufidou, Fotini, Dimou, Eleni, Pyrgelis, Efstratios-Stylianos, Constantinides, Vasilios C., Paraskevas, George P., Kapaki, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220160/ https://www.ncbi.nlm.nih.gov/pubmed/35740284 http://dx.doi.org/10.3390/biomedicines10061262

Ejemplares similares

Cerebrospinal Fluid Biomarkers in iNPH: A Narrative Review
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2022)

Cerebrospinal Fluid Biomarker Profile in TDP-43-Related Genetic Frontotemporal Dementia
por: Kapaki, Elisabeth, et al.
Publicado: (2022)

Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases
por: Kapaki, Elisabeth, et al.
Publicado: (2022)

Callosal Angle Sub-Score of the Radscale in Patients with Idiopathic Normal Pressure Hydrocephalus Is Associated with Positive Tap Test Response
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2022)

Recognizing Atypical Presentations of Alzheimer’s Disease: The Importance of CSF Biomarkers in Clinical Practice
por: Paraskevas, George P., et al.
Publicado: (2022)

CSF Aβ42 and Aβ42/Aβ40 Ratio in Alzheimer’s Disease and Frontotemporal Dementias
por: Constantinides, Vasilios C., et al.
Publicado: (2023)

Alzheimer’s Disease CSF Biomarkers as Possible Indicators of Tap-Test Response in Idiopathic Normal Pressure Hydrocephalus
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2023)

Mixed Small Vessel Disease in a Patient with Dementia with Lewy Bodies
por: Paraskevas, George P., et al.
Publicado: (2019)

Application of the AT(N) and Other CSF Classification Systems in Behavioral Variant Frontotemporal Dementia
por: Constantinides, Vasilios C., et al.
Publicado: (2023)

Imaging Markers for Normal Pressure Hydrocephalus: An Overview
por: Pyrgelis, Efstratios-Stylianos, et al.
Publicado: (2023)

An Updated Evaluation of Intrathecal IgG Synthesis Markers in Relation to Oligoclonal Bands
por: Boufidou, Fotini, et al.
Publicado: (2023)

Cerebrospinal Fluid Anti-Neuronal Autoantibodies in COVID-19-Associated Limbic Encephalitis with Acute Cerebellar Ataxia and Myoclonus Syndrome: Case Report and Literature Review
por: Yiannopoulou, Konstantina, et al.
Publicado: (2023)

From Cerebrospinal Fluid Neurochemistry to Clinical Diagnosis of Alzheimer’s Disease in the Era of Anti-Amyloid Treatments. Report of Four Patients
por: Tsantzali, Ioanna, et al.
Publicado: (2021)

Plasma P-Tau181 for the Discrimination of Alzheimer’s Disease from Other Primary Dementing and/or Movement Disorders
por: Tzartos, John S., et al.
Publicado: (2022)

Cerebrospinal fluid biomarkers and apolipoprotein E genotype in cerebral amyloid angiopathy. A narrative review
por: Theodorou, Aikaterini, et al.
Publicado: (2021)

Diffuse glioma manifesting as normal pressure hydrocephalus: A potential pitfall in diagnosis-a case report
por: Breza, Marianthi, et al.
Publicado: (2021)

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders
por: Constantinides, Vasilios C., et al.
Publicado: (2021)

Cerebrospinal Fluid and Blood Biomarkers of Neuroaxonal Damage in Multiple Sclerosis
por: Dujmovic, Irena
Publicado: (2011)

Thyroid Autoimmunity Following Alemtuzumab Treatment in Multiple Sclerosis Patients
por: Kazakou, Paraskevi, et al.
Publicado: (2021)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

Corticobasal degeneration and corticobasal syndrome: A review
por: Constantinides, Vasilios C., et al.
Publicado: (2019)

Presence of cerebrospinal fluid antibodies associated with autoimmune encephalitis of humans in dogs with neurologic disease
por: Stafford, Emma G., et al.
Publicado: (2019)

The correlation of specific medication groups and falls risk in elderly. A medication logbook survey
por: Pyrgeli, Maria, et al.
Publicado: (2017)

Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study
por: Kazakou, Paraskevi, et al.
Publicado: (2023)

Blood and Cerebrospinal Fluid α‐Tocopherol and Selenium Concentrations in Neonatal Foals with Neuroaxonal Dystrophy
por: Finno, C.J., et al.
Publicado: (2015)

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in the Era of Disease-Modifying Treatments
por: Paraskevas, George P., et al.
Publicado: (2021)

Novel PANK2 mutation in the first Greek compound heterozygote patient with pantothenate-kinase-associated neurodegeneration
por: Paraskevas, George P, et al.
Publicado: (2017)

Genotyping and Plasma/Cerebrospinal Fluid Profiling of a Cohort of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis Patients
por: Bourbouli, Mara, et al.
Publicado: (2021)

Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Chronic experimental autoimmune encephalomyelitis is an excellent model to study neuroaxonal degeneration in multiple sclerosis
por: Voskuhl, Rhonda R., et al.
Publicado: (2022)

The natural history of infantile neuroaxonal dystrophy
por: Altuame, Fadie D., et al.
Publicado: (2020)

Diabetes and Neuroaxonal Damage in Parkinson's Disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

11 Clinical Manifestations of Neuroaxonal Injury
por: Keleman, Audrey A., et al.
Publicado: (2023)

Cerebrospinal Fluid Extracellular Vesicles with Distinct Properties in Autoimmune Encephalitis and Herpes Simplex Encephalitis
por: Li, Yongang, et al.
Publicado: (2022)

Sweet syndrome on a patient with autoimmune hepatitis on azathioprine and CMV infection
por: Xenophontos, Eleni, et al.
Publicado: (2016)

Cerebrospinal fluid and serum proteomic profiles accurately distinguish neuroaxonal dystrophy from cervical vertebral compressive myelopathy in horses
por: Donnelly, Callum G., et al.
Publicado: (2023)

Infantile Neuroaxonal Dystrophy: Diagnosis and Possible Treatments
por: Babin, Patricia L., et al.
Publicado: (2018)

Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis—A Systematic Analysis
por: Blinder, Tetyana, et al.
Publicado: (2019)

Search for Viral Infections in Cerebrospinal Fluid From Patients With Autoimmune Encephalitis
por: Perlejewski, Karol, et al.
Publicado: (2020)

Advances in Potential Cerebrospinal Fluid Biomarkers for Autoimmune Encephalitis: A Review
por: Zhang, Shuyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8dsb7mbq0ej5bq7dmjs61i12k3